In examining the role of CCL2 in modulating cell adhesion molecules, vis-à-vis their migratory potential, Lin et al. [135] showed that treatment of prostate cancer cells with CCL2 induced expression of αvβ3 integrin and inhibition of the CCL2-CCR2 signaling pathway decreased migration. Here, CCR2 is linked to prostate carcinoma.